Eagle Claw Capital Managment, LLC Pfizer Inc Transaction History

Eagle Claw Capital Managment, LLC

$598 Million
Q4 2024

A detailed history of Eagle Claw Capital Managment, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 27,181 shares of PFE stock, worth $715,132. This represents 0.12% of its overall portfolio holdings.

Number of Shares

27,181

Previous 27,644 1.67%

Holding current value

$715,132

Previous $800,000 9.88%

% of portfolio

0.12%

Previous 0.14%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$24.8 - $30.19 $11,482 - $13,977	-463 Reduced 1.67%	27,181 $721,000
Q3 2024 Nov 08, 2024	SELL	$27.7 - $31.39 $20,775 - $23,542	-750 Reduced 2.64%	27,644 $800,000
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $25,890 - $29,730	1,000 Added 3.65%	28,394 $787,000
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $72,781 - $84,206	-2,015 Reduced 6.85%	27,394 $1 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $44,923 - $58,642	1,076 Added 3.8%	29,409 $1.51 Million
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $44,923 - $58,642	-1,076 Reduced 3.66%	28,333 $1.45 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $61,307 - $74,841	1,401 Added 5.0%	29,409 $1.29 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $80,310 - $95,223	-1,726 Reduced 5.8%	28,008 $1.47 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $37,743 - $46,769	-825 Reduced 2.7%	29,734 $1.54 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $24,792 - $36,750	600 Added 2.0%	30,559 $1.81 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $24,531 - $31,512	625 Added 2.13%	29,959 $1.29 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $31,815 - $35,881	950 Added 3.35%	29,334 $1.06 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $174,044 - $221,312	-5,200 Reduced 15.48%	28,384 $1.05 Million
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $203,676 - $238,958	6,415 Added 23.61%	33,584 $1.23 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $476,016 - $577,478	-15,804 Reduced 36.78%	27,169 $888,000
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $24,327 - $34,758	900 Added 2.14%	42,973 $1.4 Million
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $460,649 - $522,778	13,993 Added 49.83%	42,073 $1.65 Million
Q3 2019 Oct 22, 2019	BUY	$32.49 - $42.13 $418,341 - $542,465	12,876 Added 84.69%	28,080 $1.01 Million
Q2 2019 Jul 18, 2019	SELL	$36.98 - $41.52 $5,066 - $5,688	-137 Reduced 0.89%	15,204 $657,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $11,541 - $13,158	300 Added 1.99%	15,341 $670,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $254,181 - $308,306	7,374 Added 96.18%	15,041 $662,000
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $4,122 - $4,395	125 Added 1.66%	7,667 $278,000
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $250,846 - $266,157	7,542	7,542 $273,000

Others Institutions Holding PFE

# of Institutions

3,375

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.

Account

Eagle Claw Capital Managment, LLC Pfizer Inc Transaction History